Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Triamcinolone acetonide 40mg/1ml inj vials
1001022U0AAABAB
|
Triamcinolone acetonide (Musculoskeletal) | Triamcinolone acetonide | Musculoskeletal and Joint Diseases | 10,307 |
|
Triamcinolone acetonide 50mg/5ml inj vials
1001022U0AAACAC
|
Triamcinolone acetonide (Musculoskeletal) | Triamcinolone acetonide | Musculoskeletal and Joint Diseases | 460 |
|
Triamcinolone acetonide 10mg/1ml inj ampoules
1001022U0AAAAAA
|
Triamcinolone acetonide (Musculoskeletal) | Triamcinolone acetonide | Musculoskeletal and Joint Diseases | 175 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.